Researchers Mapped Gene Activity in 22 Million T Cells
A new public dataset provides a comprehensive look at gene regulation to accelerate the discovery of autoimmune therapies.
Updated on Oct. 13, 2026 in Life Sciences
Live Poll
Do you trust that new genetic research will lead to better treatment options for the public?
Researchers from Stanford Medicine and the Gladstone Institutes have released a dataset profiling gene activity across 22 million human T cells derived from four donors. Published in the journal Cell, the work serves as a reference for identifying genetic drivers of immune system abnormalities.
Why it matters
The study aims to provide a standardized lookup table for genetic targets, potentially shortening the timeline for developing precise medical therapies for autoimmune diseases. It serves as a foundational resource for researchers looking to link specific genetic patterns to complex immune conditions.
The researchers systematically dialed down the activity of 12,748 individual genes to observe resulting changes in T cell function. This large-scale mapping provides a granular view of gene expression that exceeds the resolution of previous localized gene studies.
The players
Stanford Medicine
An academic medical center focused on translational research and the application of genomic data to clinical care.
Gladstone Institutes
An independent biomedical research organization known for advancing work in immunology and cardiovascular disease.
The details
Scientists utilized CRISPR — a gene-editing technology that allows for precise modifications to DNA — to reduce the expression of genes one at a time. They then employed perturb-seq, a technique that sequences genetic material after specific genome aspects have been disrupted, to capture the resulting changes. By measuring these perturbations across millions of cells, the team cataloged how specific gene interference influences T cell activity.
Timeline
October 13, 2026: Dataset publication announced.
The Tech Race
This research follows the data-aggregation trajectory established by the Human Cell Atlas project by mapping specific cellular responses at a massive scale. It advances the race to digitize human immune biology by moving beyond observational sequencing to functional, perturbation-based mapping.
The dataset is now publicly available for researchers, meaning it can be immediately integrated into drug discovery workflows. It provides a new standard for identifying therapeutic targets that may lead to future treatments for autoimmune conditions.
The takeaway
This dataset provides a functional roadmap for the immune system, effectively turning raw genetic observations into a searchable index for drug developers. Watch for upcoming publications from the team regarding their ongoing profiling of regulatory T cells, which will offer further insight into immune regulation.
What happens next
The research team is currently developing a follow-up dataset focused on regulatory T cells and building new statistical methods to enable the comparison of multiple large-scale datasets.
Further reading
For more research on how genetic sequencing is transforming medicine, explore the Life Sciences section.
Source note: This article includes information reported by News Center.
Live Poll
Do you trust that new genetic research will lead to better treatment options for the public?
